ISRCTN59214686已完成3 期
Perindopril arginine/amlodipine versus valsartan/amlodipine antihypertensive strategies: efficacy and safety in mild to moderate hypertensive patients - a randomised, double-blind 6-month study followed by 8-month open label long-term follow-up with perindopril arginine/amlodipine
Institut de Recherches Internationales Servier (France)0 个研究点目标入组 1,600 人开始时间: 2010年10月25日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 1,600
研究概览
简要总结
2015 results in https://www.ncbi.nlm.nih.gov/pubmed/25380149
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Outpatients
- •2. Men or women
- •3. Aged 18 years old at least
- •4. Mild to moderate hypertensive patient
排除标准
- •1. Pregnancy or breastfeeding women
- •2. Secondary hypertension
- •3. Any patient suffering from an acute or chronic illness
- •4. Contraindication to any study treatments
研究者
相似试验
进行中（未招募）
不适用
S5985 combination versus Angiotensin II Receptor blocker/Calcium Channel Blocker: a comparison of blood pressure lowering - efficacy and safetyEssential arterial hypertensionMedDRA version: 14.1Level: LLTClassification code 10020775Term: Hypertension arterialSystem Organ Class: 100000004866EUCTR2010-020945-28-PTInstitut de Recherches Internationales Servier1,600
尚未招募
3 期
Perindopril arginine/Amlodipine versus Valsartan/Amlodipine antihypertensive startegies: Efficacy and safety in mild to moderate hypertensive patients. A randomised, double blind 6-month study followed by 8-month open label long-term follow-up with Perindopril arginine/Amlodipine.arterial hypertensionhigh blood pressure10057166NL-OMON34436Servier R&D Benelux50
进行中（未招募）
不适用
S 05985 combination versus Angiotensin II Receptor Blocker/Calcium Channel Blocker : a comparison of blood pressure lowering - efficacy and safetyEssential arterial hypertensionMedDRA version: 14.0Level: LLTClassification code 10020775Term: Hypertension arterialSystem Organ Class: 10047065 - Vascular disordersEUCTR2010-020945-28-LVInstitut de Recherches Internationales Servier1,600
进行中（未招募）
1 期
Perindopril arginine/Amlodipine versus Valsartan/Amlodipine antihypertensive strategies: Efficacy and safety in mild to moderate hypertensive patients.A randomised, double blind 6-month study followed by 8-month open label long-term follow-up with Perindopril arginine/Amlodipine.//Estrategias antihipertensivas Perindopril arginina/Amlodipino versus Valsartan/Amlodipino: Eficacia y seguridad en pacientes hipertensos de leves a moderados.Estudio aleatorizado, doble ciego durante 6 meses y que se continúa con un seguimiento a largo plazo en abierto durante 8 meses con Perindopril arginina/AmlodipinoEssential arterial hypertension//Hipertensión arterial esencialMedDRA version: 12.1Level: LLTClassification code 10020775Term: Hypertension arterialEUCTR2010-020945-28-ESItziar Fernandez Gonzalez1,600
进行中（未招募）
1 期
S 05985 combination versus Angiotensin II Receptor Blocker/Calcium Channel Blocker : a comparison of blood pressure lowering - efficacy and safetyEUCTR2010-020945-28-GBInstitut de Recherches Internationales Servier1,600